State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Lisa Saiman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Infectious Diseases and Department of Infection Prevention and Control, Columbia University Irving Medical Cent…. Hauptthemen laut MEDLINE: Cystic Fibrosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Transformative changes in care for people with cystic fibrosis (CF; pwCF) have occurred, including most recently, the widespread use of CF transmembrane regulator modulator therapy. These novel therapies improve lung function, decrease pulmonary exacerbations, increase life expectancy, and improve quality of life. Changes in the CF population have also occurred. There are now more adults than children living with CF. A growing proportion of pwCF are black and/or Hispanic, many of whom are ineligible for modulator therapy due to their CF transmembrane regulator mutations, which may further exacerbate disparities in healthcare. Management of pulmonary exacerbations—including shared decision making between pwCF and providers, the limitations of antimicrobial susceptibility testing to predict treatment response, and the role of antimicrobial stewardship—is increasingly recognized by the CF community. Collaborations among infectious diseases specialists, antimicrobial stewards, CF care teams, and clinical microbiology laboratories are increasingly needed to optimize these newer care paradigms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Infectious Diseases and Department of Infection Prevention and Control, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, New York, USA.
- Department of Pediatrics, Division of Pediatric Pulmonology, Columbia University Irving Medical Center, New York, New York, USA.
- Cystic Fibrosis Foundation, Bethesda, Maryland, USA.
- Inova Advanced Lung Disease and Lung Transplant Program, Falls Church, Virginia, USA.
ORCID-Profile: Lisa Saiman, Laurie Murray, A Whitney Brown
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Saiman, L., Murray, L., & Brown, A. W. (2025). State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf009
Vancouver
Saiman L, Murray L, Brown AW. State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf009
BibTeX
@article{Saiman2025,
author = {Saiman, Lisa and Murray, Laurie and Brown, A Whitney},
title = {State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf009}
}
EUVIMED